- Home
- A-Z Publications
- Mini Reviews in Medicinal Chemistry
- Previous Issues
- Volume 7, Issue 7, 2007
Mini Reviews in Medicinal Chemistry - Volume 7, Issue 7, 2007
Volume 7, Issue 7, 2007
-
-
Recent Advance in the Research of Flavonoids as Anticancer Agents
Authors: Yanling Li, Hao Fang and Wenfang XuFlavonoids are ubiquitously in plants which have been shown to possess a variety of biological activities at nontoxic concentrations in organisms. Compelling data indicate that flavonoids have important effects on cancer chemoprevention and chemotherapy, till now, much research has been done about their potential anticancer effect. In this review the discovery and development of flavonoids as potential anticancer agents i Read More
-
-
-
Development and Medical Application of Unsaturated Carbaglycosylamine Glycosidase Inhibitors
Authors: Seiichiro Ogawa, Miki Kanto and Yoshiyuki SuzukiThis article reviews synthesis and structures of carbaglycosylamines, a group of carbocyclic sugar analogues. Some unsaturated derivatives are known to be potent glycosidase inhibitors. Among them, N-octyl-4-epi-??-valienamine as a lysosomal ??-galactosidase inhibitor is currently undergoing a new molecular therapeutic trial (chemical chaperone therapy) for control of the human ??-galactosidase deficiency disord Read More
-
-
-
Current Evidence from Phase III Clinical Trials of Selenium Supplementation in Critically Ill Patients: Why Should We Bother?
Authors: S. P. Stawicki, Melanie Lyons, Marianne Aloupis and Babak SaraniThe importance of the trace element selenium for human health is well established. Selenium plays a central role in the formation of selenocysteine, a modified amino acid located in the catalytic center of selenoenzymes. The crucial role of selenium in these enzymes revolves around the maintenance of many redox systems in cellular and extracellular compartments. In addition, selenium plays an important rol Read More
-
-
-
Aptamer-Based Strategies for Stem Cell Research
Authors: Ke-Tai Guo, Richard Schafer, Angela Paul, Gerhard Ziemer and Hans P. WendelAptamers have been introduced to analytical applications, target validation, and drug discovery processes and, recently, applied directly as therapeutic agents. Aptamers can be generated by a method called SELEX (Systematic Evolution of Ligands by Exponential Enrichment). This is quite remarkable for such a young technology, which is only created in the early 1990s. This paper reviews recent new applications of a Read More
-
-
-
New Developments in Diketo-Containing Inhibitors of HIV-1 Integrase
Authors: Guisen Zhao, Chao Wang, Chuan Liu and Hongxiang LouHIV-1 integrase is one of the three enzymes, which are critical for viral replication. It catalyzes the integration of the HIV genome into the cellular chromosome. Since there is no known human homolog to integrase, its inhibition is one of the most promising novel drug targets for anti-retroviral therapy with potential advantage over existing therapies. To date, numerous compounds with diverse structural features have been rep Read More
-
-
-
Tumor Suppression by DNA Base Excision Repair
By G. FrosinaBase excision repair (BER) is the main pathway for repair of endogenous DNA damage. It was expected that different tumor types could derive from BER defects but to date this link is elusive. In vitro and molecular epidemiology studies may be used to unravel this issue.
-
-
-
Heme Oxygenase-1: A Fundamental Guardian Against Oxidative Tissue Injuries in Acute Inflammation
Authors: T. Takahashi, H. Shimizu, H. Morimatsu, K. Inoue, R. Akagi, K. Morita and S. SassaFree heme contributes as a major threat to the oxidative tissue injuries because it catalyzes the formation of reactive oxygen species. When free heme concentration is increased, it results in the induction of heme oxygenase-1 (HO- 1), which then breaks free heme down. As such, HO-1 plays a pivotal role in the protection of tissues from oxidative injuries.
-
-
-
Molecular Targets for the Treatment of Testicular Germ Cell Tumors
More LessIn the last decade novel therapeutic approaches for the treatment of cancer have been proposed: inhibitors of serine/threonine and tyrosine kinases, angiogenesis inhibitors, gene therapy approaches and others. In some cases the clinical trials have confirmed the efficacy of these approaches. Here, we will review the discovered molecular targets for the treatment of testicular germ cell tumors.
-
-
-
Diabetes and Metallothionein
Authors: Xiaokun Li, Lu Cai and Wenke FengDiabetes is a widespread disease, and its development and toxic effects on various organs have been attributed to increased oxidative stress. Metallothionein (MT) is a group of intracellular metal-binding and cysteine-rich proteins, being highly inducible in many tissues. Although it mainly acts as a regulator of metal homeostasis such as zinc and copper in tissues, MT was found to be a potent antioxidant and adaptive (or st Read More
-
Volumes & issues
-
Volume 25 (2025)
-
Volume 24 (2024)
-
Volume 23 (2023)
-
Volume 22 (2022)
-
Volume 21 (2021)
-
Volume 20 (2020)
-
Volume 19 (2019)
-
Volume 18 (2018)
-
Volume 17 (2017)
-
Volume 16 (2016)
-
Volume 15 (2015)
-
Volume 14 (2014)
-
Volume 13 (2013)
-
Volume 12 (2012)
-
Volume 11 (2011)
-
Volume 10 (2010)
-
Volume 9 (2009)
-
Volume 8 (2008)
-
Volume 7 (2007)
-
Volume 6 (2006)
-
Volume 5 (2005)
-
Volume 4 (2004)
-
Volume 3 (2003)
-
Volume 2 (2002)
-
Volume 1 (2001)
Most Read This Month
Article
content/journals/mrmc
Journal
10
5
false
en
